Trials / Conditions / FGFR2 Amplification
FGFR2 Amplification
4 registered clinical trials studyying FGFR2 Amplification.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer NCT05859477 | Kidney Cancer Research Bureau | Phase 2 |
| Terminated | Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib NCT05052372 | xCures | — |
| Completed | REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other NCT04526106 | Elevar Therapeutics | Phase 1 / Phase 2 |
| Terminated | A Study of TAS-120 in Patients With Metastatic Breast Cancer NCT04024436 | Taiho Oncology, Inc. | Phase 2 |